Alina Meyer
Doktorand vid Institutionen för farmaci, Läkemedelsformulering
- E-post:
- alina.meyer[AT-tecken]farmaci.uu.se
- Besöksadress:
- Biomedicinskt Centrum BMC, Husargatan 3
752 37 Uppsala - Postadress:
- Box 580
751 23 UPPSALA
Nyckelord: pkpd organoids adme drug discovery adpkd drug repurposing kidney disease drugtrain
Detta stycke finns inte på svenska, därför visas den engelska versionen.
The general aim of my PhD thesis is to pharmaceutically profile new repurposing candidates for the treatment of the hereditary kidney disease ADPKD. I will perform a series of ADME assays. Then, the intracellular compound concentration and the corresponding pharmacological effect will be investigated using 3D cultured kidney organoids and global proteomics. Furthermore, subcellular target and off-target interaction for lead candidates will be studied and the findings will be combined in a PBPK model.
The project is part of the EU 'DRUGtrain' network.
Kontakta katalogansvarig vid den aktuella organisationen (institution eller motsv.) för att rätta ev. felaktigheter.
